On September 9th, 2023, at Ta Phin Commune, Sa Pa, Lao Cai, the Board of Directors of DK Pharma held a crucial meeting to discuss the company’s vision and strategic development plan for the period of 2023-2025.
The meeting was filled with excitement and innovative business ideas.
Taking place against the backdrop of a socio-economic landscape heavily impacted by the COVID-19 pandemic and an increasingly competitive pharmaceutical industry, the meeting aimed to chart a new course for the company’s growth. The Board of Directors shared their vision, direction, and strategic development plan for DK Pharma.
Under the guidance of Chairman and General Director Nguyen Truong Giang and Head of Corporate Culture Tran Van On, along with the participation of all management levels, the conference outlined a comprehensive organizational restructuring plan. The goal is to establish a solid foundation for DK Pharma to make a breakthrough in the new phase, meet market demands, and adapt to constant changes.
The meeting delved into the continued comprehensive organizational restructuring to meet the requirements of development in the new situation, with a specific focus on key tasks in the 2023-2025 period across various areas such as product research and development, business production development, quality assurance, and corporate culture. Additionally, the Board of Directors introduced numerous innovative and promising business ideas.
Despite the challenges, all management levels demonstrated enthusiasm and strong determination in implementing the new strategy. The unwavering belief in the Board of Directors’ direction, coupled with a spirit of solidarity and unity, will be the key to DK Pharma’s success in the coming period.